Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The application of Interleukin-2 family cytokines in tumor immunotherapy research
Yangyihua Zhou, Guiqi Quan, Yujun Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Mayra Shanley, May Daher, Jinzhuang Dou, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1450-1466.e11
Open Access | Times Cited: 16
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 38
Efficacy and Safety Assessment of Intrathoracic Perfusion Chemotherapy Combined with immunological factor Interleukin-2 in the Treatment of Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study
Qiang Cao, Jinyi Zhu, Xinyan Wu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 7, pp. 2024-2032
Open Access | Times Cited: 13
GD2-targeting therapy: a comparative analysis of approaches and promising directions
Julia Philippova, Julia Shevchenko, С. В. Сенников
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy
Luhong Wang, Yiyi Jiang, Chaoyue Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189285-189285
Closed Access | Times Cited: 1
Interleukins in liver disease treatment
Ming Yang, Chunye Zhang
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 140-145
Open Access | Times Cited: 7
Advancements in Melanoma Therapies: From Surgery to Immunotherapy
Neda Shajari, Behzad Baradaran, Mohammad Reza Tohidkia, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1073-1088
Closed Access | Times Cited: 5
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 69-69
Open Access
Based on the immune system: the role of the IL-2 family in pancreatic disease
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures
A. Darragh, Andrew M. Hanna, Justin Lipner, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
Prajita Paul, Cherry Choong, Joseph Heinemann, et al.
Immunological Investigations (2025), pp. 1-15
Closed Access
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
Bailin He, Hong Chen, Jiaxu Wu, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p
Ehsan Gharib, Leili Rejali, Moein Piroozkhah, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity
Xuezhi Cao, Yang‐Xin Fu, Peng Hua
Vaccines (2024) Vol. 12, Iss. 5, pp. 477-477
Open Access | Times Cited: 3
Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis
Lazaro Revocatus Mashiku, J. P. Ndenda, Reuben S. Maghembe, et al.
Applied Mathematical Modelling (2024) Vol. 134, pp. 148-174
Closed Access | Times Cited: 3
Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer
Patrícia Rocha Martins, Kátia L.P. Morais, Nayane Alves de Lima Galdino, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
The potential role of interleukins and interferons in ovarian cancer
Huldani Huldani, Sana Ali, F. Al-dolaimy, et al.
Cytokine (2023) Vol. 171, pp. 156379-156379
Closed Access | Times Cited: 4
Establishment of reference intervals for plasma IL-2, IL-4, IL-5, and IL-17A in healthy adults from the Jiangsu region of eastern China using flow cytometry: A single-center study
Qian Liu, Zhengping Xia, Tingting Huang, et al.
Cytokine (2024) Vol. 179, pp. 156594-156594
Open Access | Times Cited: 1
The role of IL-2 cytokine family in asthma
Pouya Goleij, Mohammad Rahimi, Motahareh Pourshahroudi, et al.
Cytokine (2024) Vol. 180, pp. 156638-156638
Closed Access | Times Cited: 1
Canine Adipose-Derived Mesenchymal Stromal Cells Reduce Cell Viability and Migration of Metastatic Canine Oral Melanoma Cell Lines In Vitro
Fwu Shing Teng, Patrícia de Faria Lainetti, Mayara Simão Franzoni, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 12, pp. 636-636
Open Access | Times Cited: 1
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study
Emanuele Cencini, Anna Sicuranza, Alberto Fabbri, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 10, pp. 1634-1642
Closed Access | Times Cited: 3
Specific Targeting of Zinc Transporter LIV-1 with Immunocytokine Containing Anti-LIV-1 VHH and Human IL-2 and Evaluation of its In vitro Antitumor Activity
Rada Dehghan, Arezoo Beig Parikhani, Reza Ahangari Cohan, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 11, pp. 868-876
Closed Access
Mts1 (S100A4) and Its Peptide Demonstrate Cytotoxic Activity in Complex with Tag7 (PGLYRP1) Peptide
Daria M. Yurkina, Elena A. Romanova, K.A. Shcherbakov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6633-6633
Open Access
Targeting Radiation Resistance in Oesophageal Adenocarcinoma with Pyrazinib-Functionalised Gold Nanoparticles
Simone Marcone, Jolanda Spadavecchia, Memona Khan, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4007-4007
Open Access
Anti-CD8/IL-15 (N72D)/sushi fusion protein: A promising strategy for improvement of cancer immunotherapy
Nafiseh Maghsoodi, Mohammadrasul Zareinejad, Abbas Ghaderi, et al.
Cytokine (2024) Vol. 185, pp. 156822-156822
Closed Access
Page 1 - Next Page

Scroll to top